Sequent Scientific Limited

BSE: 512529 NSE: EQUENT
Sequent Scientific Limited - chemicals in Shaikpet, Telangana, India. FY 2026 financials and compliance.
CIN L99999TS1985PLC196357 Incorporated 28 June 1985 ROC Hyderabad HQ Shaikpet, Telangana, India
Active Listed - NSE: EQUENT · BSE: 512529 Public Limited Company chemicals
Data last updated
Revenue · FY 2026
₹3,420.31 Cr
▲ 120.47% YoY
EBITDA · FY 2026
₹696.08 Cr
▲ 294.42% YoY
Net profit · FY 2026
₹224.65 Cr
▲ 596.37% YoY
Authorised capital
₹886.15 Cr
Registered with MCA
Paid-up capital
₹50.82 Cr
Issued & subscribed
Open charges
₹792.71 Cr
Satisfied ₹1,663.84 Cr
Company age
41 yrs
Est. 1985
Employees · EPFO
399
Latest available

About Sequent Scientific Limited

Data last updated: 23 December 2025

Sequent Scientific Limited is a public limited company based in Shaikpet, Telangana, India. It specialises in pharmaceuticals, a part of the broader chemicals sector. Incorporated on 28 June 1985, the company has been in operation for over 41 years.

Registered with ROC Hyderabad under CIN L99999TS1985PLC196357. Listed on BSE: 512529 and NSE: EQUENT.

Capital: an authorised share capital of ₹886.15 Cr and a paid-up capital of ₹50.82 Cr. Formerly known as Visistha Trades & Finance Limited and P.I. Drugs & Pharmaceuticals Limited. It is led by directors including Gregory John Andrews and Fabian Martin Kausche.

Last AGM: 08 August 2025. Financial statements filed for year ended 31 March 2025. Office: Shaikpet, Telangana.

As per the financials filed for FY 2025, the company reported a revenue of ₹1,566.06 Cr, a growth of 13% compared to the previous year.

The company has a workforce of approximately 399 employees as per the latest available data. Its group structure includes 7 subsidiaries.

As per MCA filings, the company has open charges of ₹792.71 Cr and satisfied charges of ₹1,663.84 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sequent.in.

Company Details of Sequent Scientific Limited
CIN L99999TS1985PLC196357
Registration Number 196357
Incorporation Date 28 June 1985
ROC Hyderabad
Listing Status Listed (BSE: 512529, NSE: EQUENT)
Company Status Active
Date of Last AGM 08 August 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Hari Babu Bodepudi Ceo Rajaram Narayanan Whole-Time Director Gregory John Andrews Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    sequent.in
  • Social Media
  • Registered Address
    3Rd Floor Srivalli S Corporate Plot No. 290, Syn 33 34P To 39 Guttala Begumpet, Shaikpet, Telangana, India – 500033
  • Industry
    Chemicals, Pharmaceuticals, Medicinal Chemical & Botanical Products, Chemical Products
Company report
Sequent Scientific Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Sequent Scientific Limited report

Financials, compliance, directors, charges, ownership and filings for Sequent Scientific Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Sequent Scientific Limited

Sequent Scientific Limited has undergone 3 name changes throughout its history. The company was previously known as Visistha Trades & Finance Limited, P.I. Drugs & Pharmaceuticals Limited, and Visistha Trades And Finance Limited. The current legal name is Sequent Scientific Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Sequent Scientific Limited Current
Visistha Trades & Finance Limited Previous
P.I. Drugs & Pharmaceuticals Limited Previous
Visistha Trades And Finance Limited Previous

CIN History of Sequent Scientific Limited

Sequent Scientific Limited has one previous CIN (Corporate Identification Number): L99999MH1985PLC036685. The current CIN is L99999TS1985PLC196357, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L99999TS1985PLC196357 Current
L99999MH1985PLC036685 Previous

Business Activity of Sequent Scientific Limited

Sequent Scientific Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products *********

Auditor Details of Sequent Scientific Limited

Sequent Scientific Limited is audited by SRBC & CO LLP (ICAI peer reviewed, certificate valid till 2029-02-28) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
SRBC & CO LLP (ICAI peer reviewed, certificate valid till 2029-02-28) FY 2026 Declaration of unmodified opinion

Board of Directors of Sequent Scientific Limited

Sequent Scientific Limited is currently managed by 8 directors, with 42 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Gregory John Andrews
Also directs: Sequent Scientific Limited
Director 06 Nov 2020 5 Years 8 Months Current
Fabian Martin Kausche
Also directs: Sequent Scientific Limited
Director 14 Dec 2020 5 Years 6 Months Current
Revati Parag Kasture
Also directs: Sequent Scientific Limited
Director 17 Dec 2024 1 Years 6 Months Current
Milind Shripad Sarwate
Also directs: Increate Value Advisors Llp, Increate Social Value Advisors & Resourcers Llp, Asian Paints Limited and 5 more
Director 25 Aug 2020 5 Years 10 Months Current
Kamal Kishore Sharma
Also directs: Sequent Scientific Limited, Templecraft Realty Llp, Templeriviere Property Llp and 5 more
Director 25 Aug 2020 5 Years 10 Months Current
Anuj Vishnukumar Poddar
Also directs: Sequent Scientific Limited, Highway Roop Precision Technologies Limited, Vlcc Limited
Director 05 Sep 2025 0 Years 10 Months Current
Showing 6 of 8 current directors. View all directors

Financials of Sequent Scientific Limited FY 2026 filings available

Sequent Scientific Limited reported revenue of ₹3,420.31 Cr (up 120.47% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue · FY 2026
₹3,420.31 Cr ▲ 120.47%
Profit · FY 2026
₹224.65 Cr ▲ 596.37%
EBITDA · FY 2026
₹696.08 Cr ▲ 294.42%
Revenue₹ Cr · Consolidated02,0004,000FY 2020: ₹1,179 Cr1,179FY 2020FY 2021: ₹1,362 Cr · +15.5% YoY1,362+15.5%FY 2021FY 2022: ₹1,413 Cr · +3.8% YoY1,413+3.8%FY 2022FY 2023: ₹1,421 Cr · +0.6% YoY1,421+0.6%FY 2023FY 2024: ₹1,370 Cr · -3.6% YoY1,370-3.6%FY 2024FY 2025: ₹1,551 Cr · +13.3% YoY1,551+13.3%FY 2025FY 2026: ₹3,420 Cr · +120.5% YoY3,420+120.5%FY 2026
Net Profit₹ Cr · Consolidated-200-1000100200300FY 2020: ₹82 Cr82FY 2020FY 2021: ₹104 Cr · +27.3% YoY104+27.3%FY 2021FY 2022: ₹45 Cr · -56.9% YoY45.1-56.9%FY 2022FY 2023: ₹122 Cr (loss) · -370.7% YoY-122FY 2023FY 2024: ₹30 Cr (loss) · +75.7% YoY-29.6FY 2024FY 2025: ₹32 Cr · +208.9% YoY32.3+208.9%FY 2025FY 2026: ₹225 Cr · +596.4% YoY225+596.4%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year05001,000Q1'25: ₹390 Cr · +17.1% YoY390+17.1%Q1'25Q2'25: ₹369 Cr · +6.6% YoY369+6.6%Q2'25Q3'25: ₹391 Cr · +18.7% YoY391+18.7%Q3'25Q4'25: ₹402 Cr · +11.2% YoY402+11.2%Q4'25Q1'26: ₹441 Cr · +13.1% YoY441+13.1%Q1'26Q2'26: ₹424 Cr · +15% YoY424+15%Q2'26Q3'26: ₹858 Cr · +119.6% YoY858+119.6%Q3'26Q4'26: ₹920 Cr · +129% YoY920+129%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹3,420.31 Cr ₹1,551.37 Cr ₹1,369.73 Cr ₹1,420.91 Cr ₹1,412.82 Cr ₹1,361.62 Cr ₹1,179.24 Cr
Other Income ₹43.55 Cr ₹14.69 Cr ₹10.96 Cr ₹6.39 Cr ₹10.85 Cr ₹8.36 Cr ₹10.09 Cr
Total Income ₹3,463.86 Cr ₹1,566.06 Cr ₹1,380.69 Cr ₹1,427.3 Cr ₹1,423.66 Cr ₹1,369.98 Cr ₹1,189.33 Cr
Cost of Materials Consumed ₹1,376.93 Cr ₹617.37 Cr ₹613.67 Cr ₹693.1 Cr ₹670.52 Cr ₹588.67 Cr ₹508.69 Cr
Purchases of Stock-in-Trade ₹250.59 Cr ₹212.57 Cr ₹175.54 Cr ₹121.77 Cr ₹171.89 Cr ₹145.02 Cr ₹88.89 Cr
Changes in Inventories -₹64.79 Cr -₹18.09 Cr -₹29.46 Cr ₹18.9 Cr -₹49.42 Cr -₹39.03 Cr ₹7.47 Cr
Employee Benefit Expense ₹565.5 Cr ₹281.12 Cr ₹250.57 Cr ₹258.39 Cr ₹231.37 Cr ₹187.22 Cr ₹165.06 Cr
Finance Costs ₹69.21 Cr ₹60.75 Cr ₹48.09 Cr ₹35.52 Cr ₹15.77 Cr ₹24.38 Cr ₹35.71 Cr
Depreciation & Amortisation ₹233.64 Cr ₹66.45 Cr ₹61.54 Cr ₹55.69 Cr ₹51.09 Cr ₹50.6 Cr ₹50.62 Cr
Other Expenses ₹639.55 Cr ₹296.61 Cr ₹298 Cr ₹316.8 Cr ₹279.05 Cr ₹267.67 Cr ₹238.81 Cr
Total Expenses ₹3,070.63 Cr ₹1,516.78 Cr ₹1,417.94 Cr ₹1,500.16 Cr ₹1,370.28 Cr ₹1,224.53 Cr ₹1,095.26 Cr
Profit Before Exceptional Items & Tax ₹393.23 Cr ₹49.28 Cr -₹37.26 Cr -₹72.87 Cr ₹53.39 Cr ₹145.45 Cr ₹94.08 Cr
Exceptional Items -₹44.21 Cr -₹4.97 Cr -₹17.39 Cr -₹64.79 Cr ₹0 -₹8.82 Cr ₹0
Profit Before Tax ₹349.02 Cr ₹44.31 Cr -₹54.65 Cr -₹137.66 Cr ₹53.39 Cr ₹136.63 Cr ₹94.08 Cr
Total Tax Expense ₹124.37 Cr ₹12.05 Cr -₹25.03 Cr -₹15.68 Cr ₹8.33 Cr ₹32.18 Cr ₹12.03 Cr
Net Profit ₹224.65 Cr ₹32.26 Cr -₹29.61 Cr -₹121.98 Cr ₹45.06 Cr ₹104.45 Cr ₹82.05 Cr
  attributable to Owners ₹177.28 Cr ₹21.88 Cr -₹35.87 Cr -₹121.16 Cr ₹41.25 Cr ₹95.44 Cr ₹69.91 Cr
  attributable to NCI ₹47.37 Cr ₹10.38 Cr ₹6.26 Cr -₹81.8 Lakh ₹3.81 Cr ₹9.01 Cr ₹12.14 Cr
Other Comprehensive Income ₹106.9 Cr -₹21.61 Cr -₹65.15 Cr -₹26.15 Cr -₹108.66 Cr ₹64.42 Cr -₹31.79 Cr
Total Comprehensive Income ₹331.55 Cr ₹10.65 Cr -₹94.77 Cr -₹148.13 Cr -₹63.6 Cr ₹168.88 Cr ₹50.26 Cr
EBITDA (computed) ₹696.08 Cr ₹176.48 Cr ₹72.37 Cr ₹18.35 Cr ₹120.25 Cr ₹220.43 Cr ₹180.41 Cr
Basic EPS ₹4.09 ₹0.88 ₹-1.44 ₹-4.88 ₹1.67 ₹3.87 ₹2.87
Diluted EPS ₹4.01 ₹0.85 ₹-1.44 ₹-4.88 ₹1.65 ₹3.85 ₹2.85
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹4,628.39 Cr ₹1,601.95 Cr ₹1,540.38 Cr ₹1,529.12 Cr
Non-current Assets ₹2,373.84 Cr ₹728.22 Cr ₹717.53 Cr ₹739.24 Cr
Current Assets ₹2,254.55 Cr ₹872.92 Cr ₹810.94 Cr ₹779.79 Cr
Property, Plant & Equipment ₹1,137.9 Cr ₹231.62 Cr ₹248.62 Cr ₹300.74 Cr
Inventories ₹803.2 Cr ₹385.32 Cr ₹346.23 Cr ₹346.09 Cr
Trade Receivables ₹1,045.23 Cr ₹363.17 Cr ₹335.63 Cr ₹340.96 Cr
Cash & Equivalents ₹255.76 Cr ₹62.66 Cr ₹64.81 Cr ₹41.57 Cr
Equity (Net Worth) ₹3,114.73 Cr ₹770.36 Cr ₹712.96 Cr ₹749.19 Cr
Equity Share Capital ₹87.37 Cr ₹50.06 Cr ₹49.89 Cr ₹49.89 Cr
Borrowings (Non-current) ₹302.1 Cr ₹273.88 Cr ₹142.72 Cr ₹182.8 Cr
Borrowings (Current) ₹133.72 Cr ₹172.5 Cr ₹308.56 Cr ₹215.1 Cr
Total Debt (computed) ₹435.82 Cr ₹446.38 Cr ₹451.28 Cr ₹397.9 Cr
Current Liabilities ₹945.9 Cr ₹505.01 Cr ₹626.99 Cr ₹526.07 Cr
Total Liabilities ₹1,513.66 Cr ₹831.59 Cr ₹827.43 Cr ₹779.93 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹322.91 Cr ₹83.36 Cr ₹30.59 Cr ₹16.81 Cr ₹30.6 Cr
Investing Cash Flow -₹84.12 Cr -₹24.78 Cr -₹5.92 Cr -₹64.96 Cr -₹94.1 Cr
Financing Cash Flow -₹123.33 Cr -₹60.73 Cr -₹1.44 Cr ₹32.23 Cr ₹67.26 Cr
Capital Expenditure ₹134.72 Cr ₹39.09 Cr ₹30.81 Cr ₹86.18 Cr ₹32.46 Cr
Free Cash Flow (computed) ₹188.19 Cr ₹44.27 Cr -₹21.22 Lakh -₹69.37 Cr -₹1.87 Cr
Dividends Paid ₹4.91 Cr ₹1.85 Cr ₹0 ₹0 ₹12.34 Cr
Net Change in Cash ₹115.46 Cr -₹2.15 Cr ₹23.24 Cr -₹15.92 Cr ₹3.75 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹919.96 Cr ₹858.41 Cr ₹423.99 Cr ₹441.42 Cr ₹401.7 Cr ₹390.81 Cr ₹368.65 Cr ₹390.21 Cr ₹361.2 Cr ₹329.36 Cr ₹345.97 Cr ₹333.21 Cr
Other Income ₹15.92 Cr ₹13.98 Cr ₹2.15 Cr ₹3.87 Cr ₹1.66 Cr ₹5.84 Cr ₹4.51 Cr ₹2.68 Cr ₹4 Cr ₹4.52 Cr ₹1.65 Cr ₹79.3 Lakh
Total Income ₹935.88 Cr ₹872.39 Cr ₹426.14 Cr ₹445.29 Cr ₹403.36 Cr ₹396.65 Cr ₹373.16 Cr ₹392.89 Cr ₹365.2 Cr ₹333.88 Cr ₹347.62 Cr ₹334 Cr
Cost of Materials Consumed ₹363.92 Cr ₹347.29 Cr ₹182.79 Cr ₹179.69 Cr ₹159 Cr ₹169.93 Cr ₹135.34 Cr ₹153.1 Cr ₹166.37 Cr ₹145.69 Cr ₹156.62 Cr ₹144.99 Cr
Purchases of Stock-in-Trade ₹92.01 Cr ₹56.58 Cr ₹45.14 Cr ₹52.1 Cr ₹36.6 Cr ₹41.79 Cr ₹65.96 Cr ₹68.22 Cr ₹41.37 Cr ₹38.22 Cr ₹49.68 Cr ₹46.27 Cr
Changes in Inventories -₹43.1 Cr -₹12.94 Cr -₹14.83 Cr ₹2.76 Cr ₹4.14 Cr -₹9.19 Cr -₹6.01 Cr -₹7.03 Cr -₹13.2 Cr -₹3.28 Cr -₹16.53 Cr ₹3.55 Cr
Employee Benefit Expense ₹149.82 Cr ₹137.69 Cr ₹81.69 Cr ₹79.07 Cr ₹76.81 Cr ₹75.22 Cr ₹67.04 Cr ₹62.05 Cr ₹62.19 Cr ₹57.86 Cr ₹66.36 Cr ₹64.17 Cr
Finance Costs ₹14.52 Cr ₹16.75 Cr ₹13.51 Cr ₹14.16 Cr ₹15.13 Cr ₹14.95 Cr ₹14.29 Cr ₹16.38 Cr ₹12.44 Cr ₹12.58 Cr ₹12.58 Cr ₹10.48 Cr
Depreciation & Amortisation ₹60.41 Cr ₹58.53 Cr ₹15.46 Cr ₹15.13 Cr ₹16.12 Cr ₹16.98 Cr ₹17.1 Cr ₹16.25 Cr ₹16.48 Cr ₹15.46 Cr ₹15.36 Cr ₹14.24 Cr
Other Expenses ₹173.06 Cr ₹154.16 Cr ₹73.52 Cr ₹75.61 Cr ₹78.91 Cr ₹78.56 Cr ₹67.22 Cr ₹71.92 Cr ₹72.2 Cr ₹68.62 Cr ₹74.71 Cr ₹82.47 Cr
Total Expenses ₹810.64 Cr ₹758.06 Cr ₹397.28 Cr ₹418.52 Cr ₹386.71 Cr ₹388.24 Cr ₹360.94 Cr ₹380.89 Cr ₹357.85 Cr ₹335.15 Cr ₹358.78 Cr ₹366.17 Cr
Profit Before Exceptional Items & Tax ₹125.24 Cr ₹114.33 Cr ₹28.86 Cr ₹26.77 Cr ₹16.65 Cr ₹8.41 Cr ₹12.22 Cr ₹12 Cr ₹7.34 Cr -₹1.27 Cr -₹11.16 Cr -₹32.17 Cr
Exceptional Items ₹0 -₹41.26 Cr -₹1.7 Cr -₹1.25 Cr -₹34 Lakh -₹31 Lakh -₹4.32 Cr ₹0 -₹4.71 Cr ₹2.76 Cr ₹8.07 Cr -₹23.51 Cr
Profit Before Tax ₹125.24 Cr ₹73.07 Cr ₹27.16 Cr ₹25.52 Cr ₹16.31 Cr ₹8.1 Cr ₹7.9 Cr ₹12 Cr ₹2.64 Cr ₹1.49 Cr -₹3.09 Cr -₹55.68 Cr
Total Tax Expense ₹58.86 Cr ₹24.55 Cr ₹7.56 Cr ₹7.95 Cr ₹5.93 Cr ₹1.62 Cr ₹1.56 Cr ₹2.94 Cr ₹1.36 Cr -₹9.19 Cr ₹3.79 Cr -₹21 Cr
Net Profit ₹66.38 Cr ₹48.52 Cr ₹19.6 Cr ₹17.57 Cr ₹10.38 Cr ₹6.48 Cr ₹6.34 Cr ₹9.06 Cr ₹1.27 Cr ₹10.68 Cr -₹6.88 Cr -₹34.68 Cr
  attributable to Owners ₹52.11 Cr ₹38.44 Cr ₹14.74 Cr ₹14.31 Cr ₹9.32 Cr ₹3.44 Cr - ₹6.51 Cr -₹91.1 Lakh ₹8.27 Cr -₹8.38 Cr -₹34.85 Cr
  attributable to NCI ₹14.27 Cr ₹10.08 Cr ₹4.86 Cr ₹3.26 Cr ₹1.06 Cr ₹3.04 Cr - ₹2.55 Cr ₹2.19 Cr ₹2.41 Cr ₹1.5 Cr ₹16.5 Lakh
Other Comprehensive Income ₹39.02 Cr ₹2.91 Cr ₹14.35 Cr ₹31.75 Cr ₹46.75 Cr -₹56.86 Cr ₹19.29 Cr -₹30.79 Cr -₹21.69 Cr ₹4.82 Cr -₹15.29 Cr -₹32.98 Cr
Total Comprehensive Income ₹105.4 Cr ₹51.43 Cr ₹33.95 Cr ₹49.32 Cr ₹57.13 Cr -₹50.38 Cr ₹25.63 Cr -₹21.73 Cr -₹20.42 Cr ₹15.49 Cr -₹22.18 Cr -₹67.66 Cr
EBITDA (computed) ₹200.17 Cr ₹189.61 Cr ₹57.83 Cr ₹56.06 Cr ₹47.9 Cr ₹40.34 Cr ₹43.61 Cr ₹44.63 Cr ₹36.27 Cr ₹26.77 Cr ₹16.78 Cr -₹7.44 Cr
Basic EPS ₹1.20 ₹0.89 ₹0.59 ₹0.57 ₹0.37 ₹0.14 ₹0.10 ₹0.26 ₹-0.04 ₹0.33 ₹-0.34 ₹-1.40
Diluted EPS ₹1.17 ₹0.87 ₹0.58 ₹0.56 ₹0.36 ₹0.13 ₹0.10 ₹0.26 ₹-0.04 ₹0.33 ₹-0.34 ₹-1.40
Latest 12 quarters shown of 25 on record.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹1,382.06 Cr ₹178.26 Cr ₹168.52 Cr ₹222.69 Cr ₹219.63 Cr ₹265.46 Cr ₹227.33 Cr
Other Income ₹66.26 Cr ₹50.94 Cr ₹45.98 Cr ₹28.24 Cr ₹27.64 Cr ₹19.97 Cr ₹14.56 Cr
Total Income ₹1,448.32 Cr ₹229.2 Cr ₹214.5 Cr ₹250.93 Cr ₹247.27 Cr ₹285.42 Cr ₹241.89 Cr
Cost of Materials Consumed ₹599.82 Cr ₹86.91 Cr ₹102.54 Cr ₹114.07 Cr ₹124.01 Cr ₹115.88 Cr ₹108.69 Cr
Purchases of Stock-in-Trade ₹28.41 Cr ₹10.28 Cr ₹0 ₹2.42 Cr ₹4.38 Cr ₹8.55 Cr ₹8.24 Cr
Changes in Inventories -₹4.36 Cr ₹8.31 Cr ₹5.35 Cr ₹19.42 Cr -₹19.73 Cr -₹15.56 Cr -₹3.89 Cr
Employee Benefit Expense ₹213.75 Cr ₹35.05 Cr ₹30.05 Cr ₹36.66 Cr ₹27.38 Cr ₹22.42 Cr ₹17.1 Cr
Finance Costs ₹16.21 Cr ₹3.96 Cr ₹4.36 Cr ₹2.51 Cr ₹1.61 Cr ₹2.68 Cr ₹5.04 Cr
Depreciation & Amortisation ₹124.15 Cr ₹8.67 Cr ₹8.94 Cr ₹9.12 Cr ₹9.59 Cr ₹9.13 Cr ₹8.95 Cr
Other Expenses ₹309.91 Cr ₹49.09 Cr ₹57.24 Cr ₹76.47 Cr ₹84.34 Cr ₹98.88 Cr ₹74.96 Cr
Total Expenses ₹1,287.89 Cr ₹202.27 Cr ₹208.48 Cr ₹260.67 Cr ₹231.58 Cr ₹241.97 Cr ₹219.08 Cr
Profit Before Exceptional Items & Tax ₹160.43 Cr ₹26.93 Cr ₹6.02 Cr -₹9.75 Cr ₹15.69 Cr ₹43.45 Cr ₹22.81 Cr
Exceptional Items -₹44.21 Cr -₹4.88 Cr -₹6.25 Cr ₹0 ₹0 -₹2.56 Cr ₹0
Profit Before Tax ₹116.22 Cr ₹22.05 Cr -₹23.9 Lakh -₹9.75 Cr ₹15.69 Cr ₹40.89 Cr ₹22.81 Cr
Total Tax Expense ₹40.35 Cr ₹6.25 Cr -₹86.1 Lakh -₹3.67 Cr ₹89.1 Lakh ₹8.77 Cr ₹1.47 Cr
Net Profit ₹75.87 Cr ₹15.8 Cr ₹62.2 Lakh -₹6.08 Cr ₹14.8 Cr ₹32.11 Cr ₹21.34 Cr
Other Comprehensive Income -₹98 Lakh -₹15 Lakh ₹3.2 Lakh -₹12.05 Cr -₹35.32 Cr ₹90.48 Cr -₹48.58 Cr
Total Comprehensive Income ₹74.89 Cr ₹15.65 Cr ₹65.4 Lakh -₹18.13 Cr -₹20.52 Cr ₹122.59 Cr -₹27.24 Cr
EBITDA (computed) ₹300.79 Cr ₹39.56 Cr ₹19.32 Cr ₹1.88 Cr ₹26.89 Cr ₹55.26 Cr ₹36.8 Cr
Basic EPS ₹1.75 ₹0.63 ₹0.03 ₹-0.24 ₹0.60 ₹1.30 ₹0.88
Diluted EPS ₹1.72 ₹0.62 ₹0.03 ₹-0.24 ₹0.59 ₹1.30 ₹0.87
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹3,655.04 Cr ₹1,222.2 Cr ₹1,187.6 Cr ₹1,122.77 Cr
Non-current Assets ₹2,692.59 Cr ₹1,114.68 Cr ₹1,082.42 Cr ₹1,037.66 Cr
Current Assets ₹962.45 Cr ₹107.52 Cr ₹96.77 Cr ₹75.02 Cr
Property, Plant & Equipment ₹802.72 Cr ₹45.47 Cr ₹41.66 Cr ₹56.5 Cr
Inventories ₹292.87 Cr ₹25.05 Cr ₹34.54 Cr ₹47.95 Cr
Trade Receivables ₹554.26 Cr ₹68.93 Cr ₹44.79 Cr ₹13.65 Cr
Cash & Equivalents ₹20.97 Cr ₹3 Lakh ₹92.6 Lakh ₹8.3 Lakh
Equity (Net Worth) ₹3,189.07 Cr ₹1,142.65 Cr ₹1,087.23 Cr ₹1,058.36 Cr
Equity Share Capital ₹87.37 Cr ₹50.06 Cr ₹49.89 Cr ₹49.89 Cr
Borrowings (Non-current) ₹6.32 Cr ₹0 ₹0 ₹0
Borrowings (Current) ₹25.8 Cr ₹44.38 Cr ₹46.46 Cr ₹19.1 Cr
Total Debt (computed) ₹32.12 Cr ₹44.38 Cr ₹46.46 Cr ₹19.1 Cr
Current Liabilities ₹415.77 Cr ₹75.56 Cr ₹98.16 Cr ₹61.61 Cr
Total Liabilities ₹465.97 Cr ₹79.55 Cr ₹100.37 Cr ₹64.41 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹119.12 Cr -₹1.12 Cr -₹26.94 Cr ₹37.75 Cr ₹9.36 Cr
Investing Cash Flow -₹106.88 Cr -₹44 Lakh ₹5.47 Cr -₹50.7 Cr -₹4.25 Cr
Financing Cash Flow -₹7.06 Cr ₹66 Lakh ₹22.32 Cr ₹24.1 Lakh ₹7.25 Cr
Capital Expenditure ₹100.93 Cr ₹11.91 Cr ₹9.54 Cr ₹8.86 Cr ₹6.45 Cr
Free Cash Flow (computed) ₹18.19 Cr -₹13.03 Cr -₹36.48 Cr ₹28.88 Cr ₹2.92 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹12.34 Cr
Net Change in Cash ₹5.18 Cr -₹90 Lakh ₹84.3 Lakh -₹12.71 Cr ₹12.36 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹372.49 Cr ₹341.64 Cr ₹34.03 Cr ₹41.07 Cr ₹42.33 Cr ₹36.27 Cr ₹41.99 Cr ₹57.67 Cr ₹36.77 Cr ₹42.21 Cr ₹49.12 Cr ₹40.42 Cr
Other Income ₹19.75 Cr ₹16.29 Cr ₹11.75 Cr ₹11.48 Cr ₹12.27 Cr ₹11.88 Cr ₹15.95 Cr ₹10.84 Cr ₹12.98 Cr ₹13.44 Cr ₹9.87 Cr ₹9.7 Cr
Total Income ₹392.24 Cr ₹357.93 Cr ₹45.78 Cr ₹52.55 Cr ₹54.6 Cr ₹48.15 Cr ₹57.94 Cr ₹68.51 Cr ₹49.75 Cr ₹55.65 Cr ₹58.99 Cr ₹50.12 Cr
Cost of Materials Consumed ₹156.16 Cr ₹155.03 Cr ₹16.8 Cr ₹19.76 Cr ₹21.42 Cr ₹22.55 Cr ₹24.52 Cr ₹18.42 Cr ₹23.68 Cr ₹27.17 Cr ₹23.35 Cr ₹28.35 Cr
Purchases of Stock-in-Trade ₹18.21 Cr ₹5.44 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹10.28 Cr ₹0 ₹0 ₹0 ₹0
Changes in Inventories -₹4.04 Cr -₹9.66 Cr -₹1.26 Cr ₹1.72 Cr ₹87 Lakh -₹3.25 Cr -₹48 Lakh ₹11.17 Cr -₹65.7 Lakh -₹2.83 Cr ₹11.83 Cr -₹3 Cr
Employee Benefit Expense ₹57.45 Cr ₹50.1 Cr ₹9.46 Cr ₹9.48 Cr ₹10.58 Cr ₹9.3 Cr ₹8.04 Cr ₹7.13 Cr ₹7.09 Cr ₹7.12 Cr ₹7.22 Cr ₹8.62 Cr
Finance Costs ₹2.53 Cr ₹3.56 Cr ₹83 Lakh ₹1.08 Cr ₹99 Lakh ₹1.17 Cr ₹1 Cr ₹81 Lakh ₹1.03 Cr ₹1.15 Cr ₹1.21 Cr ₹98.2 Lakh
Depreciation & Amortisation ₹31.16 Cr ₹31.2 Cr ₹2.24 Cr ₹2.33 Cr ₹2.3 Cr ₹2.24 Cr ₹2.12 Cr ₹2 Cr ₹2.11 Cr ₹2.05 Cr ₹2.35 Cr ₹2.43 Cr
Other Expenses ₹82.02 Cr ₹70.39 Cr ₹11.67 Cr ₹12.15 Cr ₹12.28 Cr ₹12.15 Cr ₹12.01 Cr ₹12.65 Cr ₹12.4 Cr ₹14.9 Cr ₹14.42 Cr ₹15.53 Cr
Total Expenses ₹343.49 Cr ₹306.06 Cr ₹39.74 Cr ₹46.52 Cr ₹48.44 Cr ₹44.16 Cr ₹47.21 Cr ₹62.46 Cr ₹45.65 Cr ₹49.56 Cr ₹60.38 Cr ₹52.9 Cr
Profit Before Exceptional Items & Tax ₹48.75 Cr ₹51.87 Cr ₹6.04 Cr ₹6.03 Cr ₹6.16 Cr ₹3.99 Cr ₹10.73 Cr ₹6.05 Cr ₹4.1 Cr ₹6.09 Cr -₹1.4 Cr -₹2.78 Cr
Exceptional Items ₹0 -₹41.26 Cr -₹1.7 Cr -₹1.25 Cr -₹25 Lakh -₹31 Lakh -₹4.32 Cr ₹0 ₹0 ₹0 ₹0 -₹6.25 Cr
Profit Before Tax ₹48.75 Cr ₹10.61 Cr ₹4.34 Cr ₹4.78 Cr ₹5.91 Cr ₹3.68 Cr ₹6.41 Cr ₹6.05 Cr ₹4.1 Cr ₹6.09 Cr -₹1.4 Cr -₹9.03 Cr
Total Tax Expense ₹12.94 Cr ₹10.69 Cr ₹1.26 Cr ₹1.41 Cr ₹1.68 Cr ₹87 Lakh ₹2.15 Cr ₹1.55 Cr ₹33.7 Lakh ₹1.51 Cr -₹47.8 Lakh -₹2.23 Cr
Net Profit ₹35.81 Cr -₹8 Lakh ₹3.08 Cr ₹3.37 Cr ₹4.23 Cr ₹2.81 Cr ₹4.26 Cr ₹4.5 Cr ₹3.76 Cr ₹4.58 Cr -₹91.8 Lakh -₹6.8 Cr
Other Comprehensive Income -₹80 Lakh -₹25 Lakh ₹7 Lakh ₹0 -₹11 Lakh -₹1 Lakh -₹2 Lakh -₹1 Lakh -₹50,000 ₹30,000 ₹2.7 Lakh ₹0
Total Comprehensive Income ₹35.01 Cr -₹33 Lakh ₹3.15 Cr ₹3.37 Cr ₹4.12 Cr ₹2.8 Cr ₹4.24 Cr ₹4.49 Cr ₹3.76 Cr ₹4.58 Cr -₹89.1 Lakh -₹6.8 Cr
EBITDA (computed) ₹82.44 Cr ₹86.63 Cr ₹9.11 Cr ₹9.44 Cr ₹9.45 Cr ₹7.4 Cr ₹13.85 Cr ₹8.86 Cr ₹7.23 Cr ₹9.29 Cr ₹2.17 Cr ₹62.8 Lakh
Basic EPS ₹0.82 ₹0.00 ₹0.12 ₹0.14 ₹0.17 ₹0.11 ₹0.17 ₹0.18 ₹0.15 ₹0.18 ₹-0.04 ₹-0.27
Diluted EPS ₹0.81 ₹0.00 ₹0.12 ₹0.13 ₹0.16 ₹0.11 ₹0.17 ₹0.18 ₹0.15 ₹0.18 ₹-0.04 ₹-0.27
Latest 12 quarters shown of 25 on record.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Sequent Scientific Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Sequent Scientific Limited

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 61.31%, foreign institutional investors hold 2.94%, domestic institutional investors hold 7.99%, retail and other public shareholders hold 27.67% of Sequent Scientific Limited. The company had 127,446 shareholders on record.

Promoters: 61.31%DII (Domestic Institutional): 7.99%FII (Foreign Institutional): 2.94%Retail & Others: 27.67%
Mar 2026
QUARTER
61.31% Promoters
7.99% DII (Domestic Institutional)
2.94% FII (Foreign Institutional)
27.67% Retail & Others
Promoter holding - history
Now 61.31% · Mar 2026High 61.43% · Dec 2025Low 52.33% · Sep 2025
51%54%57%60%63%Mar 2016Sep 2018Mar 2021Sep 2023Mar 2026Mar 2016: 56.25%Jun 2016: 56.25%Sep 2016: 57.24%Dec 2016: 57.24%Mar 2017: 57.24%Jun 2017: 57.24%Sep 2017: 57.24%Dec 2017: 57.24%Mar 2018: 57.28%Jun 2018: 57.28%Sep 2018: 57.31%Dec 2018: 57.41%Mar 2019: 56.50%Jun 2019: 56.50%Sep 2019: 56.50%Dec 2019: 56.15%Mar 2020: 56.15%Jun 2020: 54.87%Sep 2020: 54.51%Dec 2020: 53.86%Mar 2021: 53.86%Jun 2021: 53.86%Sep 2021: 53.52%Dec 2021: 53.02%Mar 2022: 53.02%Jun 2022: 52.79%Sep 2022: 52.79%Dec 2022: 52.79%Mar 2023: 52.79%Jun 2023: 52.79%Sep 2023: 52.79%Dec 2023: 52.79%Mar 2024: 52.79%Jun 2024: 52.78%Sep 2024: 52.76%Dec 2024: 52.61%Mar 2025: 52.61%Jun 2025: 52.61%Sep 2025: 52.33%Dec 2025: 61.43%Mar 2026: 61.31%61.43%52.33%61.31%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters61.31%61.43%52.33%52.61%52.61%52.61%
Public38.59%38.48%47.51%47.23%47.23%47.23%
Employee Trusts0.09%0.09%0.16%0.16%0.16%0.16%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Promoters61.31%52.61%52.79%52.79%53.02%53.86%56.15%56.50%57.28%57.24%56.25%
Public38.59%47.23%47.04%46.82%46.47%45.54%41.86%41.85%42.13%42.03%42.78%
Employee Trusts0.09%0.16%0.17%0.39%0.51%0.60%1.99%1.65%0.59%0.73%0.97%
Promoter change (YoY, %pts)+8.70-0.18+0.00-0.23-0.84-2.29-0.35-0.78+0.04+0.99-

Board & Governance of Sequent Scientific Limited

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Sequent Scientific Limited has 9 directors - 3 independent and 3 executive. The board is chaired by Kamal Kishore Sharma.

DirectorPositionOn board sinceListed boards
Hari Babu Bodepudi Executive Director · CEO-MD 2023-08-07 1
Kamal Kishore Sharma Non-Executive - Independent Director · Chairperson 2020-08-25 1
Milind Shripad Sarwate Non-Executive - Independent Director 2020-08-25 6
Revati Parag Kasture Non-Executive - Independent Director 2024-12-17 1
Rajaram Narayanan Executive Director 2022-04-11 1
Srinivas Vasireddy Executive Director 2025-12-16 1
Gregory John Andrews Non-Executive - Non Independent Director 2020-11-06 1
Fabian Martin Kausche Non-Executive - Non Independent Director 2020-12-14 1
Anuj Vishnukumar Poddar Non-Executive - Non Independent Director 2025-09-05 1
Board Committees
CommitteeMembers
Audit Committee Milind Shripad Sarwate (Chairperson), Kamal Kishore Sharma, Revati Parag Kasture, Anuj Vishnukumar Poddar
Nomination and remuneration committee Milind Shripad Sarwate (Chairperson), Kamal Kishore Sharma, Anuj Vishnukumar Poddar
Stakeholders Relationship Committee Revati Parag Kasture (Chairperson), Milind Shripad Sarwate, Rajaram Narayanan, Hari Babu Bodepudi
Risk Management Committee Anuj Vishnukumar Poddar (Chairperson), Milind Shripad Sarwate, Rajaram Narayanan, Hari Babu Bodepudi, Revati Parag Kasture, Ramakant Singani
Corporate Social Responsibility Committee Kamal Kishore Sharma (Chairperson), Rajaram Narayanan, Hari Babu Bodepudi

Group Structure of Sequent Scientific Limited

Sequent Scientific Limited has 7 subsidiary companies. This group structure data is as of FY 2016. The corporate group structure reflects Sequent Scientific Limited's business expansion strategy and organizational complexity.

7
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Sequent Anti Biotics Private Limited U24230KA2010PTC053487 -
Sequent Pharmaceuticals Private Limited U24230KA2010PTC053584 -
Sequent Research Limited U24232KA2007PLC042483 -
Elysian Life Sciences Private Limited U24232KA2010PTC052742 -
Sequent Penems Private Limited U24233KA2010PTC053548 -
Alivira Animal Health Limited U74120MH2013PLC248708 -

Showing major subsidiaries. Total: 7.

Charges & Borrowings of Sequent Scientific Limited

Open charges
₹792.71 Cr
Satisfied charges
₹1,663.84 Cr
Breakdown by lending institutions
Others₹700.41 Cr
Hdfc Bank Limited₹92.30 Cr
Latest charge details
DateLenderAmountStatus
27 Oct 2025 Hdfc Bank Limited ₹38.92 Lakh Open
04 Oct 2025 Hdfc Bank Limited ₹38.92 Lakh Open
25 Sep 2025 Hdfc Bank Limited ₹17.54 Lakh Open
24 Sep 2025 Hdfc Bank Limited ₹16.53 Lakh Open
05 Mar 2025 Hdfc Bank Limited ₹24.64 Lakh Open

Total charge records: 68 View all charges

Employees and EPFO Compliance at Sequent Scientific Limited

Sequent Scientific Limited has a workforce of 399 employees as of Apr 06, 2024.

Employee count
399
Active EPFO establishments
1
Employee growth
-21.15%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Sequent Scientific Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Sequent Scientific Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Sequent Scientific Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Sequent Scientific Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Sequent Scientific Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Sequent Scientific Limited

MSME Payment Delays by Sequent Scientific Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Sequent Scientific Limited

Subsidiaries & Group Companies of Sequent Scientific Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Sequent Scientific Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Sequent Scientific Limited

MCA Filings & Documents of Sequent Scientific Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Sequent Scientific Limited

Directors
16 Dec 2025
Hari Babu Bodepudi was appointed as a CEO on 16 Dec 2025 & has been associated with this company since 6 months 24 days.
Charges
27 Oct 2025
A charge with Hdfc Bank Limited amounted to Rs. 0.39 Cr with Charge ID 101188521 was registered on 27 Oct 2025.
Charges
04 Oct 2025
A charge with Hdfc Bank Limited amounted to Rs. 0.39 Cr with Charge ID 101169395 was registered on 04 Oct 2025.
Charges
25 Sep 2025
A charge with Hdfc Bank Limited amounted to Rs. 0.18 Cr with Charge ID 101177637 was registered on 25 Sep 2025.
Charges
24 Sep 2025
A charge with Hdfc Bank Limited amounted to Rs. 0.17 Cr with Charge ID 101177005 was registered on 24 Sep 2025.
Directors
05 Sep 2025
Anuj Vishnukumar Poddar was appointed as a Director on 05 Sep 2025 & has been associated with this company since 10 months 3 days.

Recent News on Sequent Scientific Limited

Stocks that will see action today: January 22, 2025
22 Jan 2025 · Thehindubusinessline
CAM,
05 Dec 2018 · Legally India

Frequently Asked Questions about Sequent Scientific Limited

Sequent Scientific Limited is an active public limited company in the chemicals sector based in Shaikpet, Telangana, India. It was incorporated on 28 June 1985 (41+ years old) and is registered under CIN L99999TS1985PLC196357. Listed on BSE: 512529 and NSE: EQUENT. The company has 399 employees.

Sequent Scientific Limited reported revenue of ₹1,566.06 Cr for FY 2025 (up 13.00% YoY).

The current directors of Sequent Scientific Limited are:

The primary industry of Sequent Scientific Limited is chemicals. The company specifically operates in pharmaceuticals. The company is currently active in this sector.

Yes. Sequent Scientific Limited is listed on both BSE (code: 512529) and NSE (symbol: EQUENT).

Sequent Scientific Limited can be reached at the registered office: 3Rd Floor Srivalli S Corporate Plot No. 290, Syn 33 34P To 39 Guttala Begumpet, Shaikpet, Telangana, India – 500033, or through the website sequent.in.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available